Clinical Trial Detail

NCT ID NCT03141359
Title Use of High Dose Radiation Followed by Chemotherapy and Radiation to Treat Locally Advanced NSCLC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Atrium Health
Indications

lung non-small cell carcinoma

Therapies

Paclitaxel

Cisplatin

Durvalumab

Carboplatin

Etoposide

Age Groups: adult senior

No variant requirements are available.